Injectable codeine is obtainable for subcutaneous or intramuscular injection only; intravenous injection is contraindicated, as this may lead to nonimmune mast-cell degranulation and ensuing anaphylactoid response. Codeine suppositories are also marketed in certain nations. In Eire, new rules came into effect on 1 August 2010[90] about codeine, as a result https://codeingil.com/